Filter
2651
Filtered Results: 2651
Text search:
Global
Drug
Facility
Featured
Recommendations
258
New Publications
868
Language
Document type
No document type
1666
Guidelines
352
Studies & Reports
349
Manuals
112
Strategic & Response Plan
91
Training Material
31
Fact sheets
26
Situation Updates
13
Resource Platforms
6
Infographics
3
Brochures
1
App
1
Countries / Regions
India
135
Kenya
98
Ethiopia
84
Global
76
Nigeria
75
Uganda
73
South Africa
71
Tanzania
62
Malawi
59
Nepal
58
Liberia
57
Zambia
50
Sierra Leone
49
Ghana
47
Western and Central Europe
40
Bangladesh
40
Myanmar / Burma
39
Rwanda
36
Africa
35
Namibia
33
Eastern Europe
28
Ukraine
27
Lesotho
25
Zimbabwe
25
Cambodia
25
Asia
25
Philippines
23
Latin America and the Carribbean
23
South–East Asia Region
17
Syria
16
Senegal
15
Burkina Faso
15
Mozambique
15
Congo, Democratic Republic of
15
Botswana
15
Indonesia
15
Russia
12
Cameroon
11
East and Southern Africa
10
Eswatini/ Swaziland
9
South Sudan
8
Pakistan
8
West and Central Africa
7
Middle East and North Africa
7
Tajikistan
6
Benin
6
Haiti
6
Colombia
5
Laos
5
Guinea
5
Venezuela
5
Western Pacific Region
5
Eastern Europe and Central Asia
5
Sudan
5
Yemen
5
Thailand
4
Mexico
4
El Salvador
4
China
4
Afghanistan
4
Germany
4
Sri Lanka
4
Peru
3
Vietnam
3
Brazil
3
Moldova
3
Palestine
3
Georgia
3
Central African Republic
3
Libya
3
Somalia
3
North Macedonia
2
Timor Leste/ East Timor
2
Chile
2
Iran
2
Albania
2
Armenia
2
USA
2
Jordan
2
Gabon
2
France
2
Côte d’Ivoire / Ivory Coast
2
Lebanon
2
Papua New Guinea
2
Mali
2
Bhutan
2
Iraq
2
Madagascar
2
Serbia
1
Turkey
1
Gambia
1
Kazakhstan
1
Kyrgyzstan
1
Congo-Brazzaville
1
Niger
1
Uzbekistan
1
Morocco
1
Mongolia
1
Qatar
1
Bulgaria
1
Lithuania
1
Ireland
1
Saudi Arabia
1
Turkmenistan
1
Denmark
1
Maldives
1
Tunisia
1
United Kingdom
1
Portugal
1
Spain
1
Argentina
1
Romania
1
Greece
1
Ecuador
1
Authors & Publishers
Publication Years
Category
Countries
1205
Clinical Guidelines
237
Public Health
126
Women & Child Health
112
Key Resources
77
Capacity Building
47
Pharmacy & Technologies
36
Toolboxes
TB
337
HIV
295
AMR
156
COVID-19
125
Mental Health
95
Pharmacy
75
NTDs
60
Caregiver
55
Rapid Response
54
NCDs
40
Conflict
35
Ebola
33
Planetary Health
29
Refugee
27
Global Health Education
22
Disability
21
Health Financing Toolbox
20
Polio
14
Natural Hazards
9
Cholera
9
Specific Hazards
6
Zika
3
Social Ethics
2
WHO’s Country Cooperation Strategy (CCS) defines the Organization’s medium-term vision for working in and with a particular country. The CCS, developed in the context of global and national health priorities, examines the overall health situation in a country, including the state of the health s...
The document, "Progress on the Prevention and Control of Non-Communicable Diseases," reports on global efforts to reduce the impact of NCDs, such as heart disease, cancer, diabetes, and chronic respiratory diseases, following the commitments made at high-level United Nations meetings. It highlights ...
Care for persons with noncommunicable diseases (NCDs), such as cardiovascular disease, diabetes, cancer, and chronic obstructive pulmonary disease, is a major health priority for most countries worldwide, particularly for low-middle income countries where the problem seems to be worsening. Globally,...
Language influences the way we think, how we perceive reality, and how we behave. With respect to HIV, language can embody stigma and discrimination, which impacts access to testing, acquisition of HIV, and engagement with treatment. Language plays a role in supporting respect and empowerment of ind...
The Global Action Plan on Antimicrobial Resistance (AMR) calls for making AMR a core component of professional education and training. In 2018, the World Health Organization (WHO) published Competency framework for health workers’ education and training on AMR to ensure that academic institutions ...
Mpox is an emerging zoonotic disease caused by the mpox virus, a member of the Orthopoxvirus genus closely related to the variola virus that causes smallpox. Mpox was first discovered in 1958 when outbreaks of a pox-like disease occurred in monkeys kept for research. The first human case was recorde...
The increasing global trend of Antimicrobial resistance (AMR) has gradually emerged as a major public health challenge for the entire world. AMR has spread to almost all countries and regions, including Pakistan owing to the “misuse and overuse” of Antimicrobials, contributing to the increasing ...
How to address the global crisis in antibiotic research and development.
The report includes a comprehensive summary and critical evaluation of recent initiatives to overcome the barriers to achieve sustainable access to antibiotics. As antibiotic resistance will continue to develop as long as we ...
First Global Patient Safety Challenge Clean Care is Safer Care
The WHO Guidelines on Hand Hygiene in Health Care provide health-care workers (HCWs), hospital administrators and health authorities with a thorough review of evidence on hand hygiene in health care and specific recommendations to impro...
A Global Perspective
The integrated Global Action Plan for Pneumonia and Diarrhoea (GAPPD)
A global Review of evidence and practice
Multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant
tuberculosis (XDR-TB) increasingly occur in resource-constrained settings.
In the context of a national response to MDR- and XDR-TB, health workers in
TB clinics (in district hospitals and some accredited health centres) wil...
This is a detailed manual giving a step by step approach to undertaking the pharmacovigilance of antiretrovirals. It is intended to be a source of practical advice for Pharmacovigilance Centres and health professionals involved in HIV/AIDS prevention and treatment programmes. A number of WHO publica...
Guidelines for treatment of drug-susceptible tuberculosisand patient care
2017 Update
International Journal of Drug Policy 24 (2013) e91-98
Clinical guidelines for the comprehensive care of patients with drug-resistant tuberculosis
The use of Delamanid and Bedaquiline for Children with Drug-Resistant Tuberculosis.
1.HIV infections – drug therapy. 2.Anti-HIV agents – adverse effects. 3.Anti-retroviral agents. 4.Benzoxazines – adverse effects. 5.Pregnancy. 6.Disease transmission, Vertical - prevention and control. 7.Treatment outcome. I.World Health Organization
This guideline provides global, evidence-informed recommendations on a number of specific issues related to the management of severe acute malnutrition in infants and children, including in the context of HIV.
